You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CEA-positive advanced malignant solid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Hangzhou, Zhejiang, China
  • +1 more
Sep 18, 2023

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +7 more
  • CEA-targeted CAR-T cells
  • Wuhu, Anhui, China
    The First Affiliated Hospital of Wannan Medical College
Nov 9, 2023

Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Jinan (CEA CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +5 more
  • CEA CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jul 19, 2022

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Henan (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +4 more
  • CEA-targeted CAR-T cells
  • Henan, China
    He'nan Cancer Hospital
Sep 9, 2022

Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Hangzhou (CEA CAR-T cells)

Recruiting
  • Colorectal Cancer
  • +5 more
  • CEA CAR-T cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
May 30, 2022

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA-targeted CAR-T cells
  • Taiyuan, Shanxi, China
  • +1 more
Aug 24, 2023

Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

Not yet recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • Anti-mesothelin CAR-T cells
  • (no location specified)
Mar 13, 2023

Carcinoma Trial (Intravenous infusion anti-CEA-CAR-T cell)

Not yet recruiting
  • Carcinoma
  • Intravenous infusion anti-CEA-CAR-T cell
  • (no location specified)
Aug 22, 2023

Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

Recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital Zhejiang University School of Medi
May 11, 2023

Solid Tumor Trial (UCLM802 Cell Injection)

Not yet recruiting
  • Solid Tumor
  • UCLM802 Cell Injection
  • (no location specified)
Mar 7, 2023

Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen mRNA Personalised Cancer vaccine
  • (no location specified)
Jul 16, 2023

Solid Tumor Trial in Beijing (QLS31905, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 10, 2023

Advanced Solid Tumor Trial in Shanghai (RC118, Toripalimab)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, China
    hongshan Hospital Affiliated to Fudan University
Sep 14, 2023

Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Jun 20, 2023

Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)

Recruiting
  • Gastric Cancer
  • Chimeric antigen receptor T cell preparation targeting Claudin18.2
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
Jul 11, 2023

Carcinoma, Solid Tumor Trial in Suzhou (ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin)

Not yet recruiting
  • Carcinoma
  • Solid Tumor
  • ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 26, 2023

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Shanghai, Shanghai, China
    Zhongshan Hospital Fudan University
May 23, 2023

HER2-positive Advanced Solid Tumors Trial in Shanghai (DP303c)

Recruiting
  • HER2-positive Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 10, 2023

Malignant Tumors Trial (IMMH-010)

Enrolling by invitation
  • Malignant Neoplasms
  • Guangzhou, China
    Guangdong Provincial People's Hospital
Dec 30, 2022

HER-2 Positive Advanced Solid Tumors Trial (D3L-001)

Not yet recruiting
  • HER-2 Positive Advanced Solid Tumors
  • D3L-001
  • (no location specified)
Jul 20, 2023

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Advanced Malignant Solid Tumors Trial in Shanghai (CM082)

Active, not recruiting
  • Advanced Malignant Solid Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 10, 2022

Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Sep 8, 2023